UBOT ETF aims to provide 200% daily leverage on the Indxx Global Robotics and AI Thematic Index. Investing in UBOT suits those with high risk tolerance, focusing on AI and robotics sectors. UBOT's ...
ANX007 targets C1q to inhibit the complement cascade, reducing neuroinflammation and protecting photoreceptors in AMD and GA. The ARCHER trial showed significant vision loss reduction, with a 73% risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback